Knowledge of Emergency Physicians about the Management of Traumatic Dental Injuries: A Cross-sectional Study in Northern Iran.

Background: Dental trauma is a common dental public health problem among the children and adults. As the emergency departments are usually the first contact point for patients after a trauma, this study aimed to evaluate the level of knowledge of emergency medicine specialists or residents and general practitioners (GPs) working in the emergency departments about the management of traumatic dental injuries. Methods: In this descriptive cross-sectional study, all emergency medicine specialists or residents and GPs working in the emergency department of hospitals affiliated to Mazandaran University of Medical Sciences were evaluated. Data were collected using a questionnaire comprising questions on demographic information and physicians' knowledge of how to deal and manage different dental injuries. The information was analyzed using t-test and chi-square statistical test. Results: The level of knowledge was good in 71.5% of emergency medicine specialists and average in 75% of the residents and 93.4% of GPs. None of the participants had low level of knowledge about management of traumatic dental injuries. There was a statistically significant association between physicians' knowledge and their job position (P<0.001). Moreover, there were no statistically significant differences between gender and the history of participating in dental trauma courses with the level of physicians' knowledge (P>0.05). Conclusion: The results of present study highlights the need for training programs to raise the knowledge of emergency medicine residents and GPs about how to effectively manage the traumatic dental injuries in patients presenting to the emergency department.

Coronavirus Disease-2019 Pneumonia and Pulmonary Embolism: Presentation of Four Cases.

Since the beginning of the Coronavirus Disease-2019 (COVID-19) outbreak, elevated D-dimer levels as an acute-phase reactant have been reported in some patients. Additionally, the patients with pneumonia are at increased risk of developing thromboembolic events. Diagnosing acute pulmonary embolism and deep vein thrombosis can be challenging in SARS-CoV2-positive patients. Here, we report four patients with COVID-19 pneumonia to highlight the possibility of acute thromboembolism in these patients. The physicians should be aware of this complication and even consider prophylactic anticoagulant therapy in proper clinical settings. How to cite this article: Alikhani F, Aalinezhad M, Haji Rezaei M, Akbari P, Hashemi M. Coronavirus Disease-2019 Pneumonia and Pulmonary Embolism: Presentation of Four Cases. Indian J Crit Care Med 2020;24(9):873-876.

Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen.

BACKGROUND: The aim of this study was to determine the effect of Livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen. MATERIALS AND METHODS: This was an add-on nonrandomized clinical trial study on thirty selected eligible cancer patients undergoing irinotecan (8 patients) and oxaliplatin (22 patients) with diagnosed fatty liver disease-based liver ultrasonography, as well as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Patients in each group received Livergol at a dose of 140 mg daily for 1 month. ALT and AST levels as well as grade of fatty liver were evaluated before and after intervention. RESULTS: In the oxaliplatin/Livergol group, 40% and 44.4% of patients who were in Grade 2 and 3 before intervention were altered to Grades 1 and 2, respectively (P = 0.005), and in irinotecan/Livergol group, the mentioned percentages were 80% and 66.7% (P = 0.014). The mean levels of ALT and AST enzymes were decreased in both groups after tacking Livergol; however, the observed decreases were not significantly different between groups. CONCLUSION: It was concluded that the adding of Livergol to oxaliplatin and irinotecan regimens significantly improved the fatty liver of patients and none of them was superior.